The Office of Drug Control grants first commercial medicinal cannabis licence
Published
Today the Office of Drug control issued the second licence under the medicinal cannabis provisions of the Narcotic Drugs Act 1967. This is the first commercial medicinal cannabis licence and authorises the cultivation and production of Australian grown cannabis into the manufacture chain and for subsequent therapeutic supply to Australian patients.
The licence has been issued to Cannoperations Pty Ltd, a wholly owned subsidiary of the Australian company Cann Group Limited.
For any questions relating to Australia’s medicinal cannabis regulatory framework, please contact the Medicinal Cannabis Section on 02 6232 8433 or mcs@health.gov.au.
Audiences
Topics